Field Clinical Advisor - Cell Therapy - PA/NJ

Summary Cell Therapy Field Clinical Advisors (FCAs) are part of the Global Cell Therapy Clinical Operations team. They play a critical role in the successful execution of cell therapy clinical trials, driving recruitment, retention, and safety management. Additionally, they allow early insight generation. FCAs focus on clinical study protocol expertise and education, optimizing the patient journey, and cell therapy pipeline engagement. They collaborate with Clinical Development and Medical Affairs across multiple indications and departments to promote AstraZeneca's diverse cell therapy portfolio. You Will Pipeline mastery at scale: Build knowledge of AstraZeneca's cell therapy pipeline across multiple indications and assets. Convey AstraZeneca's cell therapy strategy, portfolio scope, and product differentiation; ensure compliant messaging across regions. Systematically assess educational needs across owned sites, deliver advanced protocol training, and elevate patterns to Global Clinical Development with recommendations for enterprise solutions. Capture applicable field insights (feasibility, operational bottlenecks, patient pathways) and deliver them to global and local partners to lead early risk identification and inform protocol/process adjustments. Implement targeted protocol education (e.g., inclusion/exclusion criteria application) to lift enrollment rates, reduce screen failures, and minimize attrition. Be the primary field point for protocol and clinical issues—evaluate and upscale, lead root‑cause analysis, and implement corrective/preventive actions to reduce deviations and data queries. Insight loop and continuous improvement: Systematically capture site‑level insights, summarize trends for study teams and partners, and influence protocol/process adjustments and scaling. Coordinate delivery across CTCO departments, Clinical Development, Medical Affairs, Supply/Logistics, Patient Operations, and Country Ops to ensure rapid, reliable service to partners and study sites. Maintain current knowledge of local regulations, guidelines, codes of practice, and AstraZeneca policies; translate requirements into practical site actions and support inspection readiness. Operate within AZ policies/SOPs and local regulations. Directly improve the speed, quality, and consistency of AstraZeneca's cell therapy trials—reducing cycle times, elevating protocol adherence, and accelerating patient access to innovative treatments. You Have Bachelor's degree in a health‑related field required; advanced degree (PharmD, PhD, MSc, NP/PA, MD/RN). A minimum of 5 plus years in clinical research or field‑facing roles within oncology/hematology or advanced therapies; direct cell therapy experience. Concentrated understanding of GCP, clinical trial operations, and cell therapy patient journey. Collaboration and Communication: Excellent partner management ability to translate complex protocols into practical site actions. Ability to travel at least 50‑80% regionally/nationally and internationally to support sites and program needs. Patient‑ and site‑centric mindset. Data‑informed approach to identify trends, risks, and opportunities for operational improvement. Benefits offered Qualified retirement program (401(k) plan). Paid vacation, holidays, and paid leaves. Health benefits including medical, prescription drug, dental, and vision coverage following the terms and conditions of the applicable plans. Compensation: Annual base salary ranges from $197,000 to $295,000, varying based on location, experience, and market. Eligibility for short‑term incentive bonus, equity‑based long‑term incentive program, and other compensation options. Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form. #J-18808-Ljbffr AstraZeneca